Innovation and drug development with Tetra Bio-Pharma
Tetra Bio-Pharma executives speak out about building a cannabinoid pharmaceutical company.
For this article, we sat down for a virtual fireside chat with some key...
New study shows escalation in UK opioid use over the last decade
A new study of two million opioid users has shown that prescriptions for the addictive drug codeine jumped by a factor of five between...
UK government responds to ACMD report on the misuse of fentanyl
The UK government has responded to the Advisory Council on the Misuse of Drugs (ACMD) report on the misuse of fentanyl to confirm it...
New UK laws allow healthcare workers to administer vaccines
Changes to the Human Medicine Regulations 2012 have now come into force in the UK, with new laws which will allow healthcare workers to...
UK medicines regulator joins ACSS consortium of regulators
The UK medicines regulator, Medicines and Healthcare products Regulatory Agency (MHRA) has now joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium.
The ACSS Consortium will now be known...
Cutting-edge treatments to be fast-tracked to UK patients
NHS patients could have quicker access to cutting-edge medical treatments as the UK teams up with international collaborators to fast-track the approval process.
Following the...
European Commission purchases 500,000 courses of Remdesivir
The European Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses...
MEPs call for Pharmaceutical Strategy to tackle antimicrobial resistance
MEPs have called on the European Commission to tackle antimicrobial resistance (AMR) through the new Pharmaceutical Strategy for Europe.
The European Commission’s Pharmaceutical Strategy for...
Farxiga granted Breakthrough Therapy Designation by FDA
Farxiga has been given Breakthrough Therapy Designation by the Food and Drug Administration (FDA) for patients with chronic kidney disease.
Farxiga has recently shown encouraging...
Combatting resistant depression with DMT and digital therapy
A wellbeing company is developing novel formulations of dimethyltryptamine (DMT) to help combat treatment resistant depression in combination with digital psychotherapy.
Nearly 264 million people live...
Opioid addiction warnings to be strengthened in UK
Regulators in the UK are strengthening opioid addiction and dependence warnings on patient information labels and leaflets.
The Medicines and Healthcare products Regulatory Agency (MHRA)...
Psychedelics association to bridge medical establishment and industry gap
Leaders in the field of psychedelic medicine have joined forces to create the global Psychedelic Medicine Association (PMA), which aims to bridge the gap...
Ketamine therapy insights from experts in the field
A Molecular Masterclass conference delved into the benefits, research, and policy surrounding ketamine therapy.
The masterclass explored ketamine at the intersection of clinical care, research,...
Compounding pharmacies and turbulent pharmaceutical scenarios
Market research firm Global Market Insights explores global drug shortages and the rising adoption of customised medicine in developed regions.
Compounding is one of the...
Patient distrust in pharma companies sees launch of medication Trustpilot
A unique medication Trustpilot has been launched to help amplify patients voices as research reveals that 93% lack trust in pharmaceutical companies.
DrugsDisclosed.com has been launched...
Study shows metyrapone effective for treating rare Cushing’s Syndrome
The first ever prospective study to test the safety and efficacy of metyrapone in patients with Cushing’s Syndrome in a real-life setting has shown...
Could COVID-19 lead to an increase in antimicrobial resistance?
According to a new study, the use of antibiotics in the treatment of COVID-19 could lead to an increase in antimicrobial resistance (AMR) among...
The Ketamine Conference: A Molecular Masterclass
The Ketamine Conference: A Molecular Masterclass is set to take place today, featuring a host of experts in the delivery of ketamine therapy for...
European Commission reaches agreement on potential COVID-19 vaccine
Today, the European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19.
Once the vaccine has...
First at-home treatment for spinal muscular atrophy approved by FDA
The first at-home, orally administered treatment for spinal muscular atrophy has been approved by the US Food and Drug Administration (FDA).
The treatment – Evrysdi...
